Literature DB >> 21845377

Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups.

Motohiko Kato1, Kenji Watabe, Toshimitsu Hamasaki, Miyuki Umeda, Aiko Furubayashi, Kazuo Kinoshita, Osamu Kishida, Takashi Fujimoto, Akira Yamada, Yoshifumi Tsukamoto, Shunsuke Yamamoto, Yoshihiro Kamada, Yuichi Yoshida, Shinichi Kiso, Shusaku Tsutsui, Shinji Kihara, Norio Hayashi, Yuji Matsuzawa.   

Abstract

BACKGROUND: Obesity is a risk factor for gastro-esophageal reflux disease (GERD). It is generally considered that intra-abdominal pressure in obese subjects is involved in the pathogenesis of GERD through acid exposure to the esophagus. Recently, visceral fat has been recognized as an endocrine organ that secretes various adipocytokines including adiponectin. The aim of this study was to elucidate the relation between adiponectin and erosive esophagitis.
METHODS: This was a cross-sectional retrospective observational study: 2405 consecutive subjects who underwent screening esophago-gastro-duodenoscopy with serum adiponectin measurement as part of their physical check-up programs were analyzed. Clinical factors were compared between subjects with and without erosive esophagitis. The association between adiponectin and erosive esophagitis was assessed using a bootstrapping re-sampling method after adjustment for factors that tended to be different in univariate analysis.
RESULTS: Serum adiponectin levels were significantly lower in those with erosive esophagitis (8.17 μg/ml) than in those without (10.1). The erosive esophagitis group had a greater body mass index (BMI) and waist circumference (WC) and a higher prevalence of hiatal hernia. Using the bootstrap method, with a lower adiponectin cut-off value of 3-7 μg/ml, the lower limit of the 95% confidence interval of the adjusted odds ratio consistently exceeded 1 after adjustment for BMI and hiatal hernia in men. When adjusting for WC instead of BMI, the effect of adiponectin was reduced but remained significant at a lower cut-off value (3-3.5 μg/ml).
CONCLUSIONS: Low serum adiponectin levels may be associated with an increased risk for erosive esophagitis in men.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21845377     DOI: 10.1007/s00535-011-0453-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  40 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 3.  Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Ai Kubo
Journal:  Am J Gastroenterol       Date:  2006-09-04       Impact factor: 10.864

4.  Effect of adiponectin on murine colitis induced by dextran sulfate sodium.

Authors:  Tamao Nishihara; Morihiro Matsuda; Hiroshi Araki; Kazuya Oshima; Shinji Kihara; Tohru Funahashi; Iichiro Shimomura
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

5.  The role of female and male sex hormones in the healing process of preexisting lingual and gastric ulcerations.

Authors:  A Machowska; A Szlachcic; M Pawlik; T Brzozowski; S J Konturek; W W Pawlik
Journal:  J Physiol Pharmacol       Date:  2004-07       Impact factor: 3.011

6.  Obesity is associated with increased transient lower esophageal sphincter relaxation.

Authors:  Justin Che-Yuen Wu; Lik-Man Mui; Carrian Man-Yuen Cheung; Yawen Chan; Joseph Jao-Yiu Sung
Journal:  Gastroenterology       Date:  2006-12-19       Impact factor: 22.682

7.  Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.

Authors:  Yoshihiro Kamada; Hitoshi Matsumoto; Shinji Tamura; Juichi Fukushima; Shinichi Kiso; Koji Fukui; Takumi Igura; Norikazu Maeda; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Iichiro Shimomura; Norio Hayashi
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

8.  Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Authors:  Jason M Hui; Alex Hodge; Geoffrey C Farrell; James G Kench; Adamandia Kriketos; Jacob George
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

9.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus.

Authors:  Douglas A Corley; Ai Kubo; Theodore R Levin; Gladys Block; Laurel Habel; Wei Zhao; Pat Leighton; Charles Quesenberry; Greg J Rumore; Patricia A Buffler
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

10.  Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population.

Authors:  Mun Su Kang; Dong Il Park; Se Yong Oh; Tae Woo Yoo; Seung Ho Ryu; Jung Ho Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  J Gastroenterol Hepatol       Date:  2007-10       Impact factor: 4.029

View more
  18 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.

Authors:  Siddharth Singh; Anamay N Sharma; Mohammad Hassan Murad; Navtej S Buttar; Hashem B El-Serag; David A Katzka; Prasad G Iyer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-22       Impact factor: 11.382

3.  Adiponectin inhibits murine pancreatic cancer growth.

Authors:  Motohiko Kato; Kenji Watabe; Masahiko Tsujii; Tohru Funahashi; Iichiro Shimomura; Tetsuo Takehara
Journal:  Dig Dis Sci       Date:  2014-05-07       Impact factor: 3.199

Review 4.  Impact of obesity treatment on gastroesophageal reflux disease.

Authors:  Abraham Khan; Aram Kim; Cassandra Sanossian; Fritz Francois
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 5.  Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma.

Authors:  Leo Alexandre; Elizabeth Long; Ian Lp Beales
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  High prevalence of gastroesophageal reflux symptoms in type 2 diabetics with hypoadiponectinemia and metabolic syndrome.

Authors:  Ayumu Hirata; Ken Kishida; Hideaki Nakatsuji; Kana Inoue; Aki Hiuge-Shimizu; Tohru Funahashi; Iichiro Shimomura
Journal:  Nutr Metab (Lond)       Date:  2012-01-25       Impact factor: 4.169

7.  Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.

Authors:  Jiro Watari; Kazutoshi Hori; Fumihiko Toyoshima; Noriko Kamiya; Takahisa Yamasaki; Takuya Okugawa; Haruki Asano; Zhao Liang Li; Takashi Kondo; Hisatomo Ikehara; Jun Sakurai; Toshihiko Tomita; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  BMC Gastroenterol       Date:  2013-09-26       Impact factor: 3.067

8.  Gastrointestinal symptoms in morbid obesity.

Authors:  Mustafa Huseini; G Craig Wood; Jamie Seiler; George Argyropoulos; Brian A Irving; Glenn S Gerhard; Peter Benotti; Christopher Still; David D K Rolston
Journal:  Front Med (Lausanne)       Date:  2014-12-04

9.  Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Masao Kobayakawa; John M Inadomi; Michiyo Takayama; Kanako Makino; Yasushi Iwao; Yoshinori Sugino; Takanori Kanai
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

10.  Overweight associated with increased risk of erosive esophagitis in a non-obese Taiwanese population.

Authors:  Pei-Chi Chih; Yi-Ching Yang; Jin-Shang Wu; Yin-Fan Chang; Feng-Hwa Lu; Chih-Jen Chang
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.